Bristol Myers Squibb and Johnson & Johnson have begun an educational campaign about the factor XIa pathway, laying the groundwork for a launch that could follow phase 3 readouts expected this year.

I open my emails to find yet another message from a patient about their amphetamine-dextroamphetamine (the generic form of Aderall) no longer working. Dr. Plutchik, my meds no longer seem to be ...

The Global Meloxicam Market is estimated to be valued at USD 8.15 Bn in 2025 and is expected to reach USD 12.34 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.1% from 2025 to 2032.

New data classification feature transforms how enterprises build high-quality training data, delivering up to 80% faster results and 25% improvement in consistency, without sacrificing quality SAN ...